Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

PD-L1 Positive Mutation Tumor × avelumab × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Mesothelioma, Malignant 2 Urinary Bladder Neoplasms 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 PD-L1 Positive Mutation Tumor 1 Metastatic Solid Tumors 1 Melanoma 1 Malignant Solid Tumour 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Merkel Cell 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Advanced Solid Tumors 1 Advanced Solid Tumor 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03491345 2022-08-09

K-Basket, Avelumab, Biomarker-driven, Advanced Solid Tumor

Yonsei University

Phase 2 Unknown

Other solid neoplasm

PD-L1 Positive Mutation Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡